semaglutide ckd trial (Ozempic) has a new FDA approval for chronic kidney disease related to type 2 diabetes🎉, The FLOW looked at 3533 people with type 2 diabetes who also had chronic kidney disease. They semaglutide cardiovascular benefits ckd Kidney

Like, I'm gonna say, like, as a person who is, like, just sitting here, like, watching it happen, I'm like, it's kind of cruel

In laboratory research, Tirzepatide has been studied for: Appetite regulation pathways Insulin-response signaling Metabolic efficiency Body composition research Glucose metabolism studies Researchers are particularly interested in how combining GLP-1 and GIP activity may influence broader metabolic outcomes compared to single-pathway compounds

Nature 415 , 871880 (2002) Moon, M

Consumer safety notes (e.g., dehydration, hypotension, infections) are summarized on MedlinePlus

People with documented MTHFR variants or labs suggesting impaired methylation

Semaglutide, the active ingredient in Ozempic and Wegovy, is a modified version of human GLP-1